Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
Crossref DOI link: https://doi.org/10.1136/annrheumdis-2013-205067
Published Online: 2014-06-20
Published Print: 2015-11
Update policy: https://doi.org/10.1136/crossmarkpolicy
Isenberg, David
Gordon, Caroline
Licu, Daiana
Copt, Samuel
Rossi, Claudia Pena
Wofsy, David